首页 | 本学科首页   官方微博 | 高级检索  
检索        

以CCR5为靶点的小分子抗艾滋病药物的研究与开发
引用本文:甘海峰,查晓明,吉民.以CCR5为靶点的小分子抗艾滋病药物的研究与开发[J].药学进展,2005,29(4):151-155.
作者姓名:甘海峰  查晓明  吉民
作者单位:1. 中国药科大学新药研究中心,南京,210009
2. 东南大学化学化工系,江苏,南京,210008
摘    要:综述趋化因子受体5 (CCR5 )拮抗剂的作用机制,介绍若干具代表性的小分子CCR5拮抗剂,并探讨其构效关系。CCR5属于G蛋白偶联受体超家族,是HIV- 1入侵机体细胞的主要辅助受体之一。以CCR5为为靶点的小分子抗艾滋病药物的研究与开发备受关注。

关 键 词:趋化因子受体5  小分子CCR5拮抗剂  作用机制  构效关系
文章编号:1001-5094(2005)04-0151-05
修稿时间:2004年10月28

Research and Development of CCR5-targeted Small Molecule Anti-AIDS Drugs
GAN Hai-feng,ZHA Xiao-ming,JI Min.Research and Development of CCR5-targeted Small Molecule Anti-AIDS Drugs[J].Progress in Pharmaceutical Sciences,2005,29(4):151-155.
Authors:GAN Hai-feng  ZHA Xiao-ming  JI Min
Institution:GAN Hai-feng 1,ZHA Xiao-ming 1,JI Min 2*
Abstract:Chemokine receptor 5(CCR5), a member of the G protein-coupled receptor superfamily, is one of the major co-receptors for HIV-1 infection. Research and development of CCR5-targeted small-molecular antiAIDS drugs have aroused the interest of all. Several representative small-molecular CCR5-targeted agents have been developed in recent years. Their mechanisms of action were reviewed and their structure-activity relationship was also discussed.
Keywords:CCR5  Small molecule CCR5 antagonist  Acting mechanism  Structure-activity relationship
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号